PMID: 4896110Sep 6, 1969Paper

Tumour-specific antibodies in human malignant melanoma and their relationship to the extent of the disease

British Medical Journal
M G LewisP Alexander

Abstract

Biopsy specimens and sera were obtained from 103 melanoma patients. Autoantibodies were demonstrated by (1) complement-dependent cytotoxicity of autologous melanoma cells in short-term culture; (2) complement-dependent inhibition of ribonucleic acid synthesis; (3) immunofluorescent staining of the cytoplasm of killed melanoma cells and of the surface membrane of viable melanoma cells. Over one-third of the sera studied had antibodies to autologous melanoma cells. Although for technical reasons all three tests could not be performed with the cells from every melanoma, whenever multiple testing was possible there was complete concordance. The autoantibodies were virtually confined to patients in whom the disease was not widely disseminated, and over 80% of such patients had positive sera. In a limited number of patients who have been followed autoantibodies disappeared as the disease progressed to become widely disseminated. Two patients with generalized disease developed autoantibodies following inoculation by their own irradiated tumour cells.TWO TYPES OF AUTOANTIBODIES WERE RECOGNIZED: one, active against antigen(s) in the cell surface membrane, was specific for each tumour-that is, only the autologous serum reacted-and was co...Continue Reading

References

Oct 1, 1968·Journal of the National Cancer Institute·H F OettgenG M Mills
Jun 1, 1968·The British Journal of Dermatology·M G Lewis, K Johnson
Sep 1, 1953·Cancer·W C SUMNER
Apr 1, 1962·Clinical Radiology·D W SMITHERS
May 1, 1965·Journal of Clinical Pathology·J V PULVERTAFT

❮ Previous
Next ❯

Citations

Feb 23, 1979·Archives of Dermatological Research·L SuterP M Kövary
Dec 15, 1976·Archives of Dermatological Research·C M Ackermann-Schopf
Jan 1, 1975·Archiv Für Dermatologische Forschung·V Misgeld, C Meisel
Jan 1, 1972·Archiv Für Dermatologische Forschung·G Burg, O Braun-Falco
Mar 1, 1985·Somatic Cell and Molecular Genetics·N C PopescuD C Swan
Jul 30, 1979·World Journal of Surgery·J E Goodnight, D L Morton
May 20, 1977·Zeitschrift Für Krebsforschung Und Klinische Onkologie. Cancer Research and Clinical Oncology·R W Baldwin
Dec 1, 1976·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·E KristensenR Reimann
Aug 1, 1976·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·A J Cochran
Jun 1, 1983·Cancer Genetics and Cytogenetics·R BecherA A Sandberg
Oct 1, 1978·British Journal of Plastic Surgery·T P O'ConnorD C Bodenham
Jul 8, 1978·Lancet·T A PoultonL J Nineham
Jun 1, 1997·Journal of Hepatology·G CoviniE M Tan
Aug 13, 1970·The New England Journal of Medicine·U W JehnM Skinner
Mar 18, 1971·The New England Journal of Medicine·W C Wood, D L Morton
Jun 1, 1972·The New England Journal of Medicine·E M EdynakM P Lardis
Aug 31, 1972·The New England Journal of Medicine·R T Smith
Jun 1, 1979·Proceedings of the National Academy of Sciences of the United States of America·M Y YehK E Hellström
Apr 1, 1980·Proceedings of the National Academy of Sciences of the United States of America·R G WoodburyK E Hellström
Jun 1, 1981·Proceedings of the National Academy of Sciences of the United States of America·A C MorganR A Reisfeld
Sep 1, 1973·Annals of Surgery·H F SeigerC E Buckley
Oct 1, 1974·Annals of Surgery·D L MortonF C Sparks
Feb 1, 1973·Australian and New Zealand Journal of Medicine·F M Burnet
Dec 1, 1971·The British Journal of Ophthalmology·A H Rahi
Oct 3, 1990·BMJ : British Medical Journal·B Dixon
Nov 27, 1971·British Medical Journal
Dec 4, 1971·British Medical Journal·J L Odili, G Taylor
Apr 1, 1970·Postgraduate Medical Journal·I R Mackay
Nov 15, 2001·BioDrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy·E C Hsueh
Jul 1, 1981·Journal of Neurosurgery·M L Apuzzo, M S Mitchell
Feb 1, 1979·American Journal of Ophthalmology·I A PriluckD M Ilstrup
Jan 1, 1970·American Journal of Ophthalmology·A B ReeseW C Cooper
Feb 1, 1976·American Journal of Ophthalmology·I H Leopold
Dec 31, 2015·Current Opinion in Immunology·Mathias VormehrUgur Sahin
Jun 24, 2010·Critical Reviews in Oncology/hematology·K KamposiorasN Pavlidis
Feb 14, 2014·Journal of Surgical Oncology·Diona L DamianJohn F Thompson
Oct 1, 1970·American Journal of Surgery·A J Ballantyne
Nov 1, 1973·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·U VeronesiG Balzarini
Aug 1, 1973·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·P G ElliottM G Lewis
May 1, 1975·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·T GhoseA S Macdonald

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.